Tabi is a medication used to treat prostate cancer. It is an oral tablet that works by blocking the production of testosterone, which can help to slow down the growth of cancer cells.
Composition:
Tabi contains Bicalutamide, a medication that is a non-steroidal anti-androgen.
Indications:
Tabi is indicated for the treatment of:
- Prostate cancer in combination with luteinizing hormone-releasing hormone (LHRH) agonists or surgery
- Non-metastatic prostate cancer in combination with LHRH agonists
Mechanism of Action:
Bicalutamide works by:
- Blocking the action of dihydrotestosterone (DHT), a hormone that promotes prostate cancer growth
- Inhibiting the production of testosterone, which can help to slow down the growth of cancer cells
Dosage and Administration:
The recommended dosage of Tabi is:
- 50mg taken orally once daily
- The dose should be adjusted based on the patient’s response to treatment and tolerability
Side Effects:
Common side effects of Tabi include:
- Hot flashes
- Breast tenderness or swelling
- Testicular pain
- Fatigue
- Headache
- Dizziness
- Nausea and vomiting
Serious side effects can include:
- Liver damage
- Severe allergic reactions
- Respiratory problems
- Cardiac arrhythmias
Contraindications:
Tabi is contraindicated in patients with:
- Hypersensitivity to Bicalutamide or other anti-androgens
- Severe liver disease
- Severe kidney disease
Precautions:
- Patients with a history of cardiovascular disease should be closely monitored while receiving Tabi.
- Patients with a history of liver disease should be closely monitored while receiving Tabi.
- Patients with a history of kidney disease should be closely monitored while receiving Tabi.
Patient Counseling:
- Patients should be counseled on the importance of taking their medication as directed and not missing doses.
- Patients should be instructed to report any signs of hot flashes or breast tenderness.
- Patients should be advised to report any changes in their appetite or weight loss.
Storage and Handling:
- Store at room temperature (20°C to 25°C) and protected from light.
- Do not freeze or expose to direct sunlight.
- Use within 24 months of opening.
Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.
Reviews
There are no reviews yet.